Hemic and Lymphatic Diseases

593 trials 238 recruiting

Filter these 593 trials by phase, country and sponsor.

Open in Search →

A study to investigate the efficacy and safety of fitusiran prophylaxis in male participants aged 1 to less than 12 years with hemophilia A … Recruiting

2025-521858-42-00 Hemophilia 5 2026-03-16
morPHinE clearance and glomerular filtration in the Drepanocytic in crisis in REAnimation. Recruiting

2024-511985-34-00 Evaluation of the CKD-Epi score to identify a glomerula 6 2026-03-05
A Phase 1 Study of AJ1-11095 in Adults with Myelofibrosis Failed by a JAK2 Inhibitor Recruiting

2025-522033-64-00 Myelofibrosis 1 2026-02-26
LUSPARA - Luspatercept in patients affected with rare inherited anemias Recruiting

2024-520200-26-00 Inherited anemias 4 2026-02-13
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL. Recruiting

2025-522052-13-00 Framework for Optimizing, Refining, and Unifying Manage 10 2025-12-24
A Phase 3 Study of DZD8586 versus Investigator’s Choice in r/r CLL/SLL Recruiting

2025-522669-32-00 Relapsed/Refractory Chronic Lymphocytic Leukemia/Small 5 2025-12-18
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-… Recruiting

2025-520982-39-00 Philadelphia Chromosome Positive or ABL-class Philadelp 5 2025-12-09
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial-1) Recruiting

2025-521315-39-00 Axial spondyloarthritis 1 2025-11-05
The efficacy and safety of rilzabrutinib in participants aged 10 to 65 years with sickle-cell disease Recruiting

2024-518645-17-00 Blood and lymphatic diseases 5 2025-10-07
Clinical trial to evaluate the efficacy and safety of pirtobrutinib in combination with rituximab in patients with indolent clinical forms o… Recruiting

2024-511983-97-00 Adult patients with indolent MCL who have not previousl 4 2025-09-29
Clinical study of ruxolitinib and venetoclax for children with relapsed or refractory leukemia or lymphoma with mutations in the IL-7R/JAK-S… Recruiting

2022-501867-42-01 Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic 9 2025-09-08
Medical-scientific study of dasatinib and venetoclax for children with relapsed or refractory leukemia or lymphoma with a mutation in the MA… Recruiting

2022-501866-22-00 Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic 9 2025-08-26
A Worldwide Study Testing the New Drug Lisaftoclax for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma… Recruiting

2024-514084-26-00 Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymp 5 2025-08-22
A Study to assess safety and effectiveness of Emicizumab in Patients with Type 3 Von Willebrand Disease Recruiting

2024-515622-80-00 Type 3 Von Willebrand Disease 5 2025-06-04
Long-term Follow-up study for relapsed/refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LL) patients previously treated … Recruiting

2024-516617-20-00 T-cell acute lymphoblastic Lymphoma 5 2025-05-21
A Phase 1, dose determining study of EXS73565 in participants with relapsed or refractory B‑cell malignancies. Recruiting

2024-516869-36-00 Relapsed or refractory B-cell malignancies: chronic lym 1 2025-02-17
A Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B Recruiting

2024-511814-20-00 Hemophilia 3 2024-12-10
ISASOCUT-IFM2022-05-Multicenter phase 2 study of subcutaneous isatuximab plus bortezomib, lenalidomide and dexamethasone in the treatment of… Recruiting

2024-517099-39-00 Newly diagnosed transplant ineligible multiple myeloma 4 2024-11-18
A preventive study of bleeding episodes for children with severe von Willebrand disease (VWD). Recruiting

2023-509877-22-00 severe von Willebrand Disease 5 2024-10-30
An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias (RUBY-4) Recruiting

2023-507067-19-00 Autoimmune Cytopenias (warm autoimmune hemolytic anemia 4 2024-05-15
A randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-c… Recruiting

2023-507402-13-00 Multiple myeloma 5 2024-04-03
A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressi… Recruiting

2022-502783-21-00 B-Cell Non-Hodgkin's Lymphoma 5 2024-02-20
A trial to learn if odronextamab is safe and well-tolerated and how well it works compared to rituximab combined with different types of che… Recruiting

2022-502660-20-00 Follicular lymphoma 5 2024-01-23
A Phase 3, Open-Label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Trea… Recruiting

2022-501980-42-00 Anemia associated with Chronic Kidney Disease 5 2023-12-21